InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Ways Douglas Kirk. Director active across 1 company, notably Spruce Biosciences, INC.. In total, 1 filings have been published. History available since 11 December 2025. The latest transaction was disclosed on 11 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.